December 12, 2014

In Re: Xarelto (Rivaroxaban) Products Liability Litigation

View recent docket activity


Reflects complaints, answers, motions, orders and trial notes entered from Jan. 1, 2011.
Additional or older documents may be available in Pacer.


Coverage

  1. July 09, 2021

    Bayer, Janssen Duck Louisiana Blue Cross' Xarelto Claims

    A Louisiana federal judge has thrown out claims by the state's Blue Cross and Blue Shield alleging it was tricked into paying out for subscriptions to blood thinner Xarelto after Bayer Pharma AG and Janssen Pharmaceuticals Inc. misrepresented its safety, saying the health insurer can't draw a line between any wrongdoing by drugmakers and any harm it suffered.

20 other articles on this case. View all »

Parties

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Direct access to case information and documents.
  • All significant new filings across U.S. federal district courts, updated hourly on business days.
  • Full-text searches on all patent complaints in federal courts.
  • No-fee downloads of the complaints and so much more!

TRY LAW360 FREE FOR SEVEN DAYS